| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035538740 |
| P356 | DOI | 10.1007/S00115-010-3053-1 |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/s00115-010-3053-1.pdf |
| http://link.springer.com/article/10.1007/s00115-010-3053-1/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/s00115-010-3053-1 | ||
| P698 | PubMed publication ID | 20842338 |
| P2093 | author name string | F. Holsboer | |
| P2860 | cites work | The Kraepelinian dichotomy - going, going... but still not gone | Q22241683 |
| The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia | Q24619976 | ||
| Sequencing technologies - the next generation | Q27860568 | ||
| Dynamic DNA methylation programs persistent adverse effects of early-life stress | Q28264120 | ||
| Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment | Q28295248 | ||
| Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. | Q29417150 | ||
| Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
| Stress and the brain: from adaptation to disease | Q29619381 | ||
| Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep | Q30493526 | ||
| The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety | Q33658043 | ||
| Adult-born hippocampal neurons are more numerous, faster maturing, and more involved in behavior in rats than in mice | Q33698083 | ||
| Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology | Q33991750 | ||
| The corticosteroid receptor hypothesis of depression | Q34057906 | ||
| The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies | Q34295964 | ||
| Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression | Q34740072 | ||
| The implications of gene-environment interactions in depression: will cause inform cure? | Q37235032 | ||
| Stress hormone regulation: biological role and translation into therapy | Q37540035 | ||
| Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder | Q37571848 | ||
| Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. | Q39848013 | ||
| Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated | Q43504398 | ||
| A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression | Q43598189 | ||
| Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions | Q43922336 | ||
| How can we realize the promise of personalized antidepressant medicines? | Q44045526 | ||
| The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders | Q48101414 | ||
| P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder | Q48478326 | ||
| Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. | Q48956131 | ||
| P2RX7: A bipolar and unipolar disorder candidate susceptibility gene? | Q50605593 | ||
| A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations | Q79335112 | ||
| Conditional CRH overexpressing mice: an animal model for stress-elicited pathologies and treatments that target the central CRH system | Q79660931 | ||
| Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder | Q83284423 | ||
| Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression | Q83330586 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 1306, 1308,1309-12, Passim | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Der Nervenarzt | Q15446312 |
| P478 | volume | 81 |
| Q83994891 | A new evidence and consensus-based German guidelines for diagnosis and treatment of bipolar disorders |
| Q45543199 | Biologism controversy: ethical implications for psychiatry |
| Q37155562 | Normative preconditions for the assessment of mental disorder |
| Q38724887 | Redesigning antidepressant drug discovery |
| Q41964504 | The biopsychosocial model between biologism and arbitrariness. A Commentary to H. Helmchen |
| Q84985744 | The development of depression: the role of brain-derived neurotrophic factor |
| Q87624190 | [Between psyche and brain : State of the art in psychiatry] |
Search more.